Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed)

Organization
NIH
Type
NIH
Number
RFA-CA-19-052
Comments
LOI due 30 days prior to the application due date(s) which are 10/24/19, 6/24/20, 10/22/20, and 6/23/21
Brief Description

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research.

The purpose of this FOA is to support the addition of new aims and directions to currently funded NCI P01 program projects on underlying mechanisms of resistance, preclinical design and foster development of single or combination therapies to effectively target resistant/refractory tumors and/or their microenvironment at the clinical level.